Real‐World Performance of FIT Triage for Symptomatic Colonoscopy: Analysis of the UK National Endoscopy Database ( NED )
Alimentary Pharmacology & Therapeutics · 2026
DOI: 10.1111/apt.70537 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2026. Verfasst von David Beaton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Northumbria NHS Foundation Trust, North Shields, UK. Hauptthemen laut MEDLINE: Colonoscopy, Triage, Colorectal Neoplasms, Occult Blood. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The UK has adopted faecal immunochemical testing (FIT) to triage symptomatic colonoscopy referrals.
Objective
Quantify diagnostic yield and independent effects of FIT, age, sex and symptoms on polyp and cancer detection in symptomatic colonoscopy.
Design
Nationwide analysis of prospectively collected colonoscopy reports (June 2023–August 2025) from the National Endoscopy Database. Symptomatic procedures, including iron‐deficiency anaemia (IDA), were identified and diagnostic yields calculated. Mixed‐effects logistic regression estimated adjusted odds ratios (aORs) with age, sex, symptom group and FIT. Post‐estimation margins modelled cancer yield by age, FIT and symptoms.
Results
Analysis of 447,109 symptomatic colonoscopies, with FIT recorded in 202,219 (45.2%). Overall cancer yield was 1.9% (95% CI, 1.8–1.9). Cancer yield was 3.8% (95% CI, 3.7–3.9) in FIT ≥ 10, including 2.5% (95% CI, 2.3–2.7) at age 40–49 and 0.6% (95% CI, 0.5–0.7) at age 16–39; yield in FIT < 10 was 0.3% (95% CI, 0.2–0.3). FIT concentration showed a strong, graded association with cancer risk, weaker association with large polyps, and minimal association with small polyps. IDA was associated with higher cancer risk versus rectal bleeding (aOR 2.2, 95% CI, 2.0–2.3; p < 0.01). With FIT < 10, cancer yield exceeded 1% only in IDA patients aged > 80 and remained < 0.5% otherwise. A model combining FIT, age, and IDA detected > 94% of cancers while reducing colonoscopy demand by > 40%.
Conclusion
This national analysis demonstrates the superiority of FIT‐based triage over symptom‐based referral, with FIT ≥ 10 identifying high‐risk patients, including those aged 40–49, while FIT < 10 indicated very low risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Northumbria NHS Foundation Trust, North Shields, UK.
- Population Health Sciences Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle-upon-Tyne, UK.
- North Tees and Hartlepool NHS Foundation Trust, Stockton-on-Tees, UK.
- Torbay and South Devon NHS Foundation Trust, Torquay, UK.
ORCID-Profile: David Beaton, Mahmoud Mohamed, Linda Sharp, Keith Pohl, Matthew Rutter
Zitieren
APA
Beaton, D., Mohamed, M., Sharp, L., Pohl, K., & Rutter, M. (2026). Real‐World Performance of FIT Triage for Symptomatic Colonoscopy: Analysis of the UK National Endoscopy Database ( NED ). Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70537
Vancouver
Beaton D, Mohamed M, Sharp L, Pohl K, Rutter M. Real‐World Performance of FIT Triage for Symptomatic Colonoscopy: Analysis of the UK National Endoscopy Database ( NED ). Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70537
BibTeX
@article{Beaton2026,
author = {Beaton, David and Mohamed, Mahmoud and Sharp, Linda and Pohl, Keith and Rutter, Matthew},
title = {Real‐World Performance of FIT Triage for Symptomatic Colonoscopy: Analysis of the UK National Endoscopy Database ( NED )},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.70537}
}
EUVIMED